Tocilizumab Treatment of COVID-19

　　The first part of this animation explains the inflammatory storm caused by an overactive immune response is the critical cause of mortality in severe COVID-19 patients. The second part demonstrates that the Tocilizumab treatment developed from the University of Science and Technology of China (USTC) has contributed to the fight against COVID-19.
　　...

08 04, 2020

Resource Center Helps Virology Researchers

The Chinese Academy of Sciences' resource center, which pools all genome sequence data and related information about the novel coronavirus, has proved popular with researchers worldwide.？The 2019 Novel Coronavirus Resource Center offers free and open access for all researchers and health workers around the world to download the resources they need.？Sinc...

03 04, 2020

DICP’s New Catalytic Materials Efficiently Adsorb and Inactivate COVID-19 Virus

Current global outbreak of COVID-19 is disrupting almost everyone's daily life. Virus inactivation prior to contact is an effective strategy for personal protection. Recently, DICP researchers successfully developed new catalytic materials exhibiting a direct capability of adsorbing and inactivating the COVID-19 virus, with an exceptionally high steriliza...

03 04, 2020

Nelfinavir is active against SARS-CoV-2 in Vero E6 cells

01 04, 2020